{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:26:24Z","timestamp":1794936384063,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In the United States, over 80% of tuberculosis (TB) disease cases are estimated to result from reactivation of latent TB infection (LTBI) acquired more than 2 years previously (\u201creactivation TB\u201d). We estimated reactivation TB rates for the US population with LTBI, overall, by age, sex, race\u2013ethnicity, and US-born status, and for selected comorbidities (diabetes, end-stage renal disease, and HIV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We collated nationally representative data for 2011\u20132012. Reactivation TB incidence was based on TB cases reported to the National TB Surveillance System that were attributed to LTBI reactivation. Person\u2013years at risk of reactivation TB were calculated using interferon-gamma release assay (IGRA) positivity from the National Health and Nutrition Examination Survey, published values for interferon-gamma release assay sensitivity and specificity, and population estimates from the American Community Survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>For persons aged \u22656 years with LTBI, the overall reactivation rate was estimated as 0.072 (95% uncertainty interval: 0.047, 0.12) per 100 person-years. Estimated reactivation rates declined with age. Compared to the overall population, estimated reactivation rates were higher for persons with diabetes (adjusted rate ratio [aRR] = 1.6 [1.5, 1.7]), end-stage renal disease (aRR = 9.8 [5.4, 19]), and HIV (aRR = 12 [10, 13]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In our study, individuals with LTBI faced small, non-negligible risks of reactivation TB. Risks were elevated for individuals with medical comorbidities that weaken immune function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001707","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:00:52Z","timestamp":1706637652000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States"],"prefix":"10.1097","volume":"35","author":[{"given":"Mina","family":"Ekramnia","sequence":"first","affiliation":[{"name":"Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam B.","family":"Haddad","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Steve","family":"Kammerer","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Swartwood","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard TH Chan School of Public Health, Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Robert","family":"Horsburgh","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology, Biostatistics, and Global Health, Boston University School of Public Health and Department of Medicine, Boston University School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[{"name":"Center for Health Policy\/Center for Primary Care and Outcomes Research, Stanford University, Stanford CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-016X","authenticated-orcid":false,"given":"Nicolas A.","family":"Menzies","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston MA"},{"name":"Center for Health Decision Science, Harvard TH Chan School of Public Health, Boston MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"R2-20250801","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"R4-20250801","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jama.2023.4899","article-title":"Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement.","volume":"329","year":"2023","journal-title":"JAMA"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1056\/NEJMsa031667","article-title":"Priorities for the treatment of latent tuberculosis infection in the United States.","volume":"350","author":"Horsburgh","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/S1473-3099(20)30728-3","article-title":"Quantifying the rates of late reactivation tuberculosis: a systematic review.","volume":"21","author":"Dale","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.","volume":"179","author":"Shea","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10903-020-01065-8","article-title":"Estimated latent tuberculosis infection prevalence and tuberculosis reactivation rates among Non-US-born residents in the United States, from the 2011-2012 national health and nutrition examination survey.","volume":"23","author":"Yelk Woodruff","year":"2021","journal-title":"J Immigr Minor Health"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"R12-20250801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020.","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"e3476","DOI":"10.1093\/cid\/ciaa857","article-title":"Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas.","volume":"73","author":"Jo","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201907-1289OC","article-title":"Comparative modeling of tuberculosis epidemiology and policy outcomes in California.","volume":"201","author":"Menzies","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"e0249012","DOI":"10.1371\/journal.pone.0249012","article-title":"State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.","volume":"16","author":"Mirzazadeh","year":"2021","journal-title":"PLoS One"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwv121","article-title":"A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States.","volume":"182","author":"France","year":"2015","journal-title":"Am J Epidemiol"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis \u2014 United States, 2011\u20132014.","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"R19-20250801","first-page":"17","article-title":"Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis.","volume":"13","author":"Nava-Aguilera","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.03.00019103","article-title":"Risk factors for recent transmission of Mycobacterium tuberculosis.","volume":"22","author":"Heldal","year":"2003","journal-title":"Eur Respir J"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","article-title":"Evaluating latent tuberculosis infection diagnostics using latent class analysis.","volume":"73","author":"Stout","year":"2018","journal-title":"Thorax"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.amepre.2019.12.010","article-title":"Tuberculosis infection among people with diabetes: United States population differences by race\u2013ethnicity.","volume":"58","author":"Haddad","year":"2020","journal-title":"Am J Prev Med"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples.","volume":"9","author":"Lumley","year":"2004","journal-title":"J Stat Softw"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent.","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"R33-20250801","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/cid\/cix632","article-title":"Glycemic control and the prevalence of tuberculosis infection: a population-based observational study.","volume":"65","author":"Martinez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R34-20250801","first-page":"1","article-title":"National health and nutrition examination survey: estimation procedures, 2011-2014.","volume":"177","author":"Chen","year":"2018","journal-title":"Vital Health Stat 2"},{"key":"R35-20250801","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2105\/AJPH.87.4.574","article-title":"The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics.","volume":"87","author":"Pablos-M\u00e9ndez","year":"1997","journal-title":"Am J Public Health"},{"key":"R36-20250801","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"R37-20250801","first-page":"1","article-title":"Report of the NIH panel to define principles of therapy of HIV infection.","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"R39-20250801","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1164\/rccm.200909-1355OC","article-title":"Revisiting rates of reactivation tuberculosis: a population-based approach.","volume":"182","author":"Horsburgh","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-20250801","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.5588\/ijtld.17.0041","article-title":"Latent tuberculous infection testing among HIV-infected persons in clinical care, United States, 2010-2012.","volume":"21","author":"Reaves","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"R41-20250801","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/jit418","article-title":"Reversion and conversion of interferon-\u03b3 release assay results in HIV-1\u2013infected individuals.","volume":"209","author":"Aichelburg","year":"2013","journal-title":"J Infect Dis"},{"key":"R42-20250801","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1471-2334-10-206","article-title":"Birth cohort effect on latent tuberculosis infection prevalence, United States.","volume":"10","author":"Winston","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R43-20250801","first-page":"20201635","article-title":"Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease.","volume":"288","author":"Emery","year":"2021","journal-title":"Proc Biol Sci"},{"key":"R44-20250801","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/cid\/ciab668","article-title":"Trends, mechanisms, and racial\/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States.","volume":"74","author":"Kim","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R45-20250801","doi-asserted-by":"crossref","first-page":"k2738","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the timetable of tuberculosis.","volume":"362","author":"Behr","year":"2018","journal-title":"BMJ"},{"key":"R46-20250801","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.","volume":"9","author":"Suthar","year":"2012","journal-title":"PLoS Med"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:03:41Z","timestamp":1754060621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001707","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}